Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
While leading economists fret about a reckoning to come for emerging market debt in the wake of the coronavirus pandemic, for vast swathes of EM issuers bond market business is brisk. Despite dire data and forecasts, dollar funding costs for some sovereigns are nearing pre-crisis levels as investors grasp at any sort of yield. The rally may have further to run, write Ross Lancaster and Oliver West. -
Financial market participants have watched in disbelief this week as asset prices have kept rising, while US cities burn, unemployment breaks records, a global depression becomes more likely and the coronavirus pandemic still rages.
-
Programmes to cut the debts owed to official and private creditors would deliver much-needed financial assistance to emerging markets hit by the Covid-19 pandemic, according to a report by leading economists.
-
Cboe Global Markets has decided to delay its return to open outcry pit trading, amid city closures across Chicago.
-
Moody’s put aircraft ABS issuers AerCap, Aircastle, ACG, Avolon and DAE on review for downgrades due to the slower than expected recovery of the travel industry. The update follows a series of negative headlines, including AerCap’s delay of aircraft deliveries and the bankruptcy of LATAM Airlines.
-
The European Central Bank delivered a welcome — and bigger than expected — increase to both the size and scale of its Pandemic Emergency Purchase Programme (Pepp) on Thursday, causing eurozone periphery spreads to ratchet in while staving off concerns of debt sustainability for the moment. Lewis McLellan reports.
